{"id":31286,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"la-necessite-du-remboursement-des-traitements-biologiques","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/","title":{"rendered":"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1473 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018<\/h2>\n<p>Un \u00e9pisode tr\u00e8s important de d\u00e9bats relatifs aux traitements biologiques et aux besoins de remboursement. Tous les pan\u00e9listes discutent de la question du point de vue des autorit\u00e9s m\u00e9dicales et sanitaires. Les m\u00e9decins partagent leurs avis sur les traitements innovants et expliquent le nombre de phases que comprennent les \u00e9tudes actuelles, ainsi que la mani\u00e8re dont ces informations peuvent \u00eatre utilis\u00e9es comme donn\u00e9es \u00e9conomiques pour argumenter en termes d\u2019efficacit\u00e9 pour les patients et d\u2019am\u00e9lioration de la qualit\u00e9 de vie, mais aussi pour r\u00e9duire le co\u00fbt global de la maladie.  <\/p>\n<h3>Pan\u00e9listes<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1474 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/ibJ8ZcNGvXk?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Un \u00e9pisode tr\u00e8s important de d\u00e9bats relatifs aux traitements biologiques et aux besoins de remboursement. Tous les pan\u00e9listes discutent de la question du point de vue des autorit\u00e9s m\u00e9dicales et sanitaires. Les m\u00e9decins partagent leurs avis sur les traitements innovants et expliquent le nombre de phases que comprennent les \u00e9tudes actuelles, ainsi que la mani\u00e8re dont ces informations peuvent \u00eatre utilis\u00e9es comme donn\u00e9es \u00e9conomiques pour argumenter en termes d\u2019efficacit\u00e9 pour les patients et d\u2019am\u00e9lioration de la qualit\u00e9 de vie, mais aussi pour r\u00e9duire le co\u00fbt global de la maladie. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.<\/p>\n","protected":false},"author":1,"featured_media":31306,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[189],"tags":[170,175,190,191,192],"class_list":["post-31286","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-professionnels-de-sante","tag-biotherapies","tag-rhinologie","tag-debats","tag-rhinology-future-debates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La n\u00e9cessit\u00e9 du remboursement des traitements biologiques - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques\" \/>\n<meta property=\"og:description\" content=\"Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Un \u00e9pisode tr\u00e8s important de d\u00e9bats relatifs aux traitements biologiques et aux besoins de remboursement. Tous les pan\u00e9listes discutent de la question du point de vue des autorit\u00e9s m\u00e9dicales et sanitaires. Les m\u00e9decins partagent leurs avis sur les traitements innovants et expliquent le nombre de phases que comprennent les \u00e9tudes actuelles, ainsi que la mani\u00e8re dont ces informations peuvent \u00eatre utilis\u00e9es comme donn\u00e9es \u00e9conomiques pour argumenter en termes d\u2019efficacit\u00e9 pour les patients et d\u2019am\u00e9lioration de la qualit\u00e9 de vie, mais aussi pour r\u00e9duire le co\u00fbt global de la maladie. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/\",\"name\":\"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/la-necessite-du-remboursement-des-traitements-biologiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/","og_locale":"fr_FR","og_type":"article","og_title":"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques","og_description":"Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Un \u00e9pisode tr\u00e8s important de d\u00e9bats relatifs aux traitements biologiques et aux besoins de remboursement. Tous les pan\u00e9listes discutent de la question du point de vue des autorit\u00e9s m\u00e9dicales et sanitaires. Les m\u00e9decins partagent leurs avis sur les traitements innovants et expliquent le nombre de phases que comprennent les \u00e9tudes actuelles, ainsi que la mani\u00e8re dont ces informations peuvent \u00eatre utilis\u00e9es comme donn\u00e9es \u00e9conomiques pour argumenter en termes d\u2019efficacit\u00e9 pour les patients et d\u2019am\u00e9lioration de la qualit\u00e9 de vie, mais aussi pour r\u00e9duire le co\u00fbt global de la maladie. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.","og_url":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/","url":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/","name":"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/la-necessite-du-remboursement-des-traitements-biologiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"La n\u00e9cessit\u00e9 du remboursement des traitements biologiques"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=31286"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/31306"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=31286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=31286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=31286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}